Ocular Therapeutix, Inc
OCUL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001393434
In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Ocular Therapeutix, Inc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 140 | 132 | −8 |
| Shares | 41.5M | 43.5M | +1.97M (+4.7%) |
| Value | $289.1M | $215.4M | −$73.7M (−25.5%) |
New holders (16)
Institutions that held Ocular Therapeutix, Inc at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Federated Hermes, Inc. | 622,280 | $3.08M | 0.01% |
| Los Angeles Capital Management LLC | 350,288 | $1.73M | 0.01% |
| Bank of Montreal | 210,937 | $1.08M | 0.00% |
| Trexquant Investment LP | 71,224 | $353.0K | 0.02% |
| Gsa Capital Partners LLP | 57,620 | $285.0K | 0.04% |
| Paradigm Capital Management Inc | 40,000 | $198.0K | 0.01% |
| Bayesian Capital Management, LP | 14,000 | $69.0K | 0.01% |
| Amalgamated Financial Corp. | 12,519 | $62.0K | 0.00% |
| Algert Global LLC | 11,857 | $59.0K | 0.00% |
| ExodusPoint Capital Management, LP | 11,306 | $56.0K | 0.00% |
| Provident Investment Management, Inc. | 10,850 | $54.0K | 0.01% |
| HRT Financial LP | 10,370 | $51.0K | 0.00% |
| Leonteq Securities AG | 7,000 | $34.6K | 0.00% |
| FMR LLC | 2,138 | $11.0K | 0.00% |
| IFP Advisors, Inc | 1,500 | $10.0K | 0.00% |
| Group One Trading, L.P. | 1,058 | $5.00K | 0.00% |
Sold out (24)
Institutions that held Ocular Therapeutix, Inc at the end of Q4 2021 and filed for Q1 2022 without it.